Advanced Search
Contact | Corporate | Help

The Effect of GLP-1 on the Inhibition of Glucagon Secretion

Sponsors:
  • University Hospital, Gentofte, Copenhagen
Phases:
IndicationsAcronym:
  • Type 2 Diabetes
  • Type 1 Diabetes
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
  • Drug: NaCl
  • Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
  • Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
Enrollment:
30

Additional information about NCT01507597.


SourceSolution © 2008-2012